Gerald E. Archer

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

James M. Schuster, R. K. Lai, Lawrence D. Recht et al. · Neuro-Oncology · 2015 · 406 citations · Full text

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

John H. Sampson, Kenneth Aldape, Gerald E. Archer et al. · Neuro-Oncology · 2010 · 357 citations · Full text

Greater Chemotherapy-induced Lymphopenia, Tumor-specific Immune Responses, Immunology +18

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

John H. Sampson, Gamal Akabani, Gerald E. Archer et al. · Neuro-Oncology · 2008 · 192 citations · Full text

Isolation and Generation of Human Dendritic Cells

Smita K. Nair, Gerald E. Archer, Thomas F. Tedder · Current Protocols in Immunology · 2012 · 146 citations · Full text

Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor function

Peter A. Humphrey, Lisa M. Gangarosa, Albert J. Wong et al. · Biochemical and Biophysical Research Communications · 1991 · 102 citations

Neuro-oncology, Receptor Tyrosine Kinase, Type Ii Mutation +10